Table 2. Breast tumor characteristics of CCSS cases included in this study.
Subject | Age at BC | Type BC | Histology | Grade a | ER | Ki-67 |
---|---|---|---|---|---|---|
CCSS1 | 27 | Invasive | Ductal | UNK | Negative | High |
CCSS2 | 39 | Invasive | Ductal | Intermediate | Positive | Low |
CCSS3 | 38 | Invasive | Ductal | High | Negative | High |
CCSS4 | 35 | In Situ | DCIS+LCIS | Low | Positive | Low |
CCSS5 | 38 | Invasive | Ductal | High | Negative | High |
CCSS6 | 39 | Invasive | Ductal | Intermediate | Positive | High |
CCSS7 | 30 | Invasive | Ductal | High | Positive | High |
CCSS8 | 31 | Invasive | Ductal | Low | Positive | Low |
CCSS9 | 49 | Invasive | Invasive locular+DCIS | UNK | Positive | High |
CCSS10 | 39 | In Situ | DCIS | High | Positive | Low |
CCSS11 | 38 | Invasive | Ductal | High | ND | High |
CCSS12 | 44 | Invasive | Ductal | High | Negative | High |
CCSS13 | 36 | Invasive | Ductal | Intermediate | Positive | High |
CCSS14 | 45 | Invasive | Ductal | High | Negative | High |
CCSS15 | 36 | Invasive | Lobular | Intermediate | Positive | High |
CCSS16 | 38 | Invasive | Ductal | Intermediate | Positive | ND |
CCSS17 | 37 | In Situ | DCIS | Intermediate | Positive | High |
CCSS18 | 42 | Invasive | Ductal | High | Negative | High |
CCSS19 | 40 | Invasive | Ductal | High | Positive | High |
CCSS20 | 48 | Invasive | Ductal | High | Positive | High |
CCSS21 | 40 | Invasive | Ductal | High | Positive | High |
CCSS22 | 42 | Invasive | Ductal | Intermediate | Negative | High |
CCSS23 | 42 | Invasive | Ductal | Intermediate | Positive | ND |
CCSS24 | 40 | In Situ | DCIS | High | ND | ND |
CCSS25 | 37 | Invasive | Ductal | UNK | ND | ND |
CCSS26 | 42 | Invasive | Ductal | Intermediate | Positive | ND |
CCSS27 | 40 | Invasive | Ductal | High | Negative | ND |
CCSS28 | 48 | Invasive | Ductal | Low | Positive | ND |
CCSS29 | 40 | Invasive | Ductal | UNK | Positive | ND |
CCSS30 | 42 | Invasive | Ductal | Low | Positive | Low |
CCSS31 | 42 | Invasive | Ductal | UNK | ND | ND |
CCSS32 | 37 | Invasive | Ductal | High | Negative | ND |
Abbreviations: BC = breast cancer, DCIS = ductal cell in situ, ER = estrogen receptor, ND = not determined, UNK = unknown.
aGrade: low = well differentiated or grade I, intermediate = moderately differentiated or grade II, high = poorly differentiated or grade III.